Om Megashree Pharmaceuticals IPO Allotment Concludes: Lucky 147,600 Applicants Allotted 10 Units Each via Lottery System

The IPO allotment of Om Megashree Pharmaceuticals Limited is concluded today at the premises of the issue manager Prabhu Capital Limited, Lazimpat, Kathmandu.

Om Megashree Pharmaceuticals Limited had issued 18,00,000 units worth Rs 18 crores as an Initial Public Offering (IPO) to the general public (27th Falgun- 3rd Chaitra, 2081).

Out of 18,00,000 units, 90,000 (i.e., 5% of 18,00,000) were set aside for mutual funds, and 54,000 (i.e., 3% of 18,00,000) units were set aside for the company's employees. The remaining 14,76,000 units were issued to the general public at a par value of Rs. 100.

The issue received applications from 18,48,298 valid applicants who applied for a total of 2,12,82,420 units. It was oversubscribed more than 14.41 times.

As per the allotment module, a total of 147,600 applicants were allotted 10 units each via lottery, and the remaining 17,00,698 applicants were returned with empty hands.

In total, 200,527 applicants who applied for 31,38,150 units were rejected.

Allotment Module:

The IPO result can be accessed by CDSC IPO Result,  MeroShare, and Prabhu Capital

CARE Ratings Nepal Limited (CRNL) has reaffirmed the ‘CARE-NP BB- (Is)’ rating for Om Megashree Pharmaceuticals Limited (OMPL), indicating a moderate default risk for timely financial obligations. Additionally, CRNL has reaffirmed the ‘CARE-NP BB-’ rating for OMPL’s long-term bank facilities and the ‘CARE-NP A4’ rating for its short-term bank facilities.

Om Megashree Pharmaceuticals Limited, established on June 12, 2016, is a public limited company in Nepal promoted by a group of institutional and individual investors. The company manufactures pharmaceutical products at its Chitwan-based plant and began partial operations on February 19, 2024.